CD276 is a type I transmembrane protein with two extracellular IgC and variable (IgV) domains [63], mainly expressed on tumor cells, including breast cancer, renal cell carcinoma, NSCLC, endometrial cancer, and ovarian cancer cells [64]. This evidence concerns the gene CD276 and ovarian carcinoma.